CardiacWire
SEPTEMBER 11, 2024
age, 54% women, 50% White), finding that a whopping 2M (6.8%) of them had been diagnosed with AFib. AFib rates increased dramatically during the study period, from 4.49% in 2005-2009 to 6.82% in 2015-2019. the researchers estimate that at least 10.55M Americans are currently diagnosed with AFib, representing 4.48% the U.S.
Ken Grauer, MD
FEBRUARY 15, 2024
Given the irregular irregularity of beats #4-through 17 — Is this a run of AFib ( A trial Fib rillation ) with aberrant conduction? This raises the question if beats #4-thru-17 might represent a run of AFib with aberrant conduction? QUESTIONS: How would YOU interpret the ECG shown in Figure-1 ? What do YOU see?
Medical Xpress - Cardiology
FEBRUARY 22, 2024
Patients who present with persistent atrial fibrillation at diagnosis are more likely to have certain risk factors as compared with patients with occasional atrial fibrillation (AFib). The findings, led by investigators in the Smidt Heart Institute at Cedars-Sinai, published in Circulation: Arrhythmia and Electrophysiology.
American College of Cardiology
JULY 25, 2024
Device-recognized atrial fibrillation (AFib) may be associated with a higher risk of all-cause mortality in patients with cardiac implantable electronic devices (CIEDs), according to a study published in Circulation.
MIBHS
JANUARY 31, 2025
Detection of Irregular Heart Rhythms Devices such as the Apple Watch or Fitbit Sense can detect irregular heart rhythms, including atrial fibrillation (AFib). These early warnings are critical, as AFib increases the risk of stroke and other heart-related complications. Sleep Monitoring Quality sleep is essential for heart health.
DAIC
FEBRUARY 2, 2024
The results support the use of workflows to reduce radiation exposure during catheter ablation for the treatment of paroxysmal atrial fibrillation (AFib) while maintaining safety, efficacy, and long-term patient outcomes comparable to traditional procedures.1 Circulation Research. Int J Stroke. 2021 Feb;16(2):217-221.
DAIC
MARCH 28, 2024
"Based on the results from the admIRE clinical trial, we are confident that this innovation has the promise to deliver significant value and differentiated capabilities, and become an important tool for the treatment of AFib." 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib. Circulation Research.
Expert insights. Personalized for you.
105 
Let's personalize your content